Investment Rating - The industry is rated as "Buy" with an expectation of leading market benchmark returns by over 15% in the next 6-12 months [6]. Core Insights - The commercial aerospace sector has emerged as one of the strongest market themes recently, with space photovoltaics being a core beneficiary [2]. - Recent catalysts in the commercial aerospace sector include the establishment of the Commercial Space Administration and the issuance of the "Action Plan for Promoting High-Quality and Safe Development of Commercial Aerospace (2025-2027)" [2]. - Elon Musk's announcement at the 2026 Davos World Economic Forum regarding Tesla and SpaceX's plan to build a total of 200GW photovoltaic capacity in the U.S. over the next three years is a key driver for stock price increases in the sector [3]. - The transition from ground-based photovoltaic applications to space photovoltaics represents a significant shift in usage scenarios, driving technological evolution and capacity expansion [4]. Summary by Sections Industry Overview - The commercial aerospace sector is experiencing rapid development due to policy support, increasing demand for low-orbit satellite constellations, and capital market activity [2]. - The demand for space photovoltaics is expected to grow significantly as commercial aerospace scales up [2]. Technological Development - The technology path for space photovoltaics has evolved through several iterations, leading to advancements in gallium arsenide technology and the development of ultra-thin P-type HJT and perovskite tandem technologies [4]. Investment Recommendations - Companies that have strategically positioned themselves in the space photovoltaics sector, such as Junda Co., Dongfang Risheng, JinkoSolar, and Trina Solar, are expected to gain first-mover advantages and valuation premiums [5]. - Continuous growth in demand for new technology production equipment related to space photovoltaics suggests investment opportunities in companies like Maiwei Co., Jiejia Weichuang, Aotwei, and Shuangliang Energy [5].

Investment Rating - The report maintains an "Overweight" rating for the pharmaceutical and biotechnology industry [5]. Core Insights - The report highlights the strong performance of WuXi AppTec and its subsidiaries, indicating robust growth momentum in the CXO sector. WuXi AppTec is expected to achieve a revenue of CNY 45.456 billion in 2025, representing a year-on-year increase of 15.84%, with TIDES business revenue projected to grow over 90% [2][21]. - The report emphasizes the recovery and structural upgrade trends in the CXO industry, driven by the resurgence of demand and the warming of investment in the innovative drug supply chain [23]. Summary by Sections Market Review - Last week, the pharmaceutical and biotechnology index fell by 0.39%, outperforming the CSI 300 index by 0.23 percentage points but underperforming the ChiNext index by 1.50 percentage points, ranking 27th among 31 sub-industries [1][16]. Company Performance - WuXi AppTec's subsidiaries reported strong earnings forecasts, with WuXi Biologics adding 209 comprehensive projects in 2025, two-thirds of which are bispecific antibodies and ADC drugs. The company aims for a compound annual growth rate of 30%-35% in revenue from 2025 to 2030 [2][22]. - The report recommends focusing on CXO chain companies such as WuXi AppTec (A+H), WuXi Biologics (H), and WuXi AppTec's subsidiaries, indicating a positive outlook for these firms [23][27]. Investment Strategy - The report suggests that future investments in the pharmaceutical sector should increasingly focus on the clinical value of drugs, driven by domestic and international policy changes. It highlights the importance of innovative drug supply chains and high-end medical devices, recommending companies like Mindray Medical and United Imaging Healthcare [3][25]. Financial Projections - Key companies are projected to show significant growth, with earnings per share (EPS) and price-to-earnings (PE) ratios indicating strong investment potential. For instance, WuXi AppTec is expected to have an EPS of CNY 5.07 in 2025, with a PE ratio of 19 [4]. Clinical Development Updates - Recent clinical developments include new applications for drugs from companies like InnoCare Pharma and Hengrui Medicine, with several drugs in various clinical trial phases [31][32]. Market Dynamics - The report notes that the pharmaceutical manufacturing industry experienced a year-on-year revenue decline of 2.0% in the first eleven months of 2025, indicating challenges in the sector [52]. Policy and Economic Environment - The report discusses the structural shift in domestic policies favoring innovative drugs and the anticipated global demand growth due to aging populations, which is expected to benefit the pharmaceutical industry [26].

要点 本周小结： 2026 年供需偏紧仍支持铜价上行。截至 2026 年 1 月 23 日，SHFE 铜收盘价 101340 元/吨，环比 1 月 16 日+0.57%；截至 2026 年 1 月 23 日，LME 铜收盘价 13129 美元/吨，环比 1 月 16 日+2.54%。（1）宏观：市场对美联储 2026 年 1 月不降息已经基本定价。（2）供需：TC 现货价续创新低，显示铜精 矿现货采购依然紧张；线缆企业开工率本周环比回升，但国内社会库存继续增长， 铜价大涨对需求有压制；但展望 2026 年，供需依然偏紧，继续看好铜价上行。 库存：国内铜社库环比+2.9%，LME 铜库存环比+16.9%。（1）港口铜精矿库存： 截至 2026 年 1 月 23 日，国内主流港口铜精矿库存 71.9 万吨，环比上周+4.1%。 （2）全球电解铜库存：截至 2026 年 1 月 23 日，全球三大交易所库存合计 96.0 万吨，环比 1 月 16 日+6.2%。截至 1 月 22 日，LME 铜全球库存 17.2 万吨，环 比+16.9%；SMM 铜社会库存 33.0 万吨，环比 1 月 16 日+2.9%。截至 ...

2026 年 1 月 25 日 公司研究 贷款增速稳中有进，五年规划圆满收官 010-57378035 执业证书编号：S0930521090001 dongwx@ebscn.com | 市场数据 | | | --- | --- | | 总股本(亿股) | 72.49 | | 总市值(亿元)： | 1,107.65 | | 一年最低/最高(元)： | 13.04/17.14 | | 近 3 月换手率： | 64.99% | 股价相对走势 资料来源：Wind ——杭州银行（600926.SH）2025 年业绩快报点评 买入（维持） 当前价：15.28 元 作者 分析师：王一峰 执业证书编号：S0930519050002 010-57378038 wangyf@ebscn.com 分析师：董文欣 | 收益表现 | | | | | --- | --- | --- | --- | | % | 1M | 3M | 1Y | | 相对 | -1.74 | -4.83 | -14.23 | | 绝对 | -0.26 | -3.93 | 9.40 | | 资料来源：Wind | | | | 要点 事件： 1 月 23 日，杭州 ...

Strategy Overview - The report suggests maintaining a steady investment approach and holding stocks through the holiday season, anticipating a continued slight upward trend in the market despite some sector differentiation and reduced trading enthusiasm [1] - It is expected that the market will experience a new upward momentum after the Spring Festival, with historical data indicating a higher probability of index gains in the 20 trading days following the holiday [1] - Growth and small-cap styles are expected to outperform in the spring market, with a focus on sectors such as semiconductors, AI hardware, and new energy [1] Key Industries Renewable Energy - The photovoltaic sector is catalyzed by commercial space news, with plans for significant solar capacity expansion by SpaceX and Tesla [2] - The hydrogen and ammonia sector is expected to receive more investment during the 14th Five-Year Plan due to supportive policies [2] - The European offshore wind industry remains robust, with order fulfillment expected to continue [2] - Focus on energy storage and lithium battery upstream materials, particularly lithium carbonate and lithium hexafluorophosphate [2] Petrochemicals - The strategic value of deep-sea resource development is highlighted amid geopolitical tensions, with China National Offshore Oil Corporation leading in offshore resource development [2] - The company is expected to strengthen its oil and gas operations while exploring marine mineral resources [2] Construction Materials - The construction materials sector is entering a traditional off-season, with infrastructure investment expected to maintain a front-loaded pace despite high base effects from the previous year [2] - Key investments from the State Grid focus on power grid and energy storage, with significant projects planned for 2026 [2] Electronics and Communication - AI is identified as a core theme in electronics, with significant capital expenditure growth expected from major cloud providers [5] - The storage industry is projected to see substantial revenue growth, particularly in DRAM [5] - Investment opportunities are highlighted in AI, storage, and Huawei's Ascend series chips [5] Machinery Manufacturing - The engineering machinery sector is experiencing accelerated export growth, with recommendations to focus on leading manufacturers and component suppliers [5] - Data center equipment demand is rising, suggesting investment in related manufacturers [5] Automotive - The automotive market is expected to be driven by policy, with a slight decline in retail sales forecasted for 2026 [5] - Structural investment opportunities are anticipated in components, particularly for companies with strong performance [5] Financials - The insurance sector is expected to perform well in early 2026, benefiting from a favorable investment environment [5] - The banking sector is showing signs of recovery, with a focus on retail and small business lending [5] Pharmaceuticals - The medical device sector is at a low valuation, with strong earnings growth expected from leading companies [6] - The CXO sector is poised for growth due to stable order increases and geopolitical risks easing [6] Consumer Goods - The tourism sector is expected to thrive during the Spring Festival, with recommendations to focus on leading OTA and hotel companies [6] - The food and beverage sector is entering a peak sales season, with attention on performance during the holiday period [6]

Investment Rating - The report maintains a "Buy" rating for the banking industry, indicating an expected investment return exceeding the market benchmark index by over 15% in the next 6-12 months [1]. Core Insights - The 2025 annual report on the banking wealth management market highlights five key characteristics: (1) a significant increase in wealth management scale by nearly 3.3 trillion yuan, (2) the rise of "fixed income+" products as a crucial growth driver amid a recovering capital market, (3) a decline in wealth management yields below 2%, (4) an increase in the allocation of wealth management to deposit-like assets reaching 28.2%, and (5) a stable number of wealth management companies at 32, with market share exceeding 90% [1][4][7]. Summary by Sections Scale - The wealth management scale increased by approximately 3.34 trillion yuan in 2025, achieving a year-on-year growth of 11.2%, with the end-of-year scale expected to be between 33-34 trillion yuan [4][9]. - The second half of 2025 contributed 78.4% of the total scale increase, with significant growth driven by factors such as deposit "disintermediation" and the release of "floating profits" [4][5]. Product Structure - Fixed income products maintained a stable share of around 97%, with "fixed income+" products growing by 16% to 10.8 trillion yuan [15][17]. - The structure of fixed income products showed a balance between cash management and non-cash management products, with cash management products at 7.04 trillion yuan [15]. Asset Allocation - The allocation to deposit-like assets increased to 28.2%, driven by the need for stability in net value and the relative yield advantages of deposits [23][25]. - Public funds saw an increase of 8.9 trillion yuan, with a notable contribution from the second and fourth quarters [25][26]. Wealth Management Returns - The average yield for wealth management products in 2025 was 1.98%, reflecting a decline compared to previous periods, with expectations for further weakening in 2026 [38][40]. Customer Behavior - The number of wealth management investors reached 143 million, with a strong preference for low-risk and medium-low-risk products, reflecting a conservative risk appetite among individual investors [42][44]. Competitive Landscape - The market share of wealth management companies reached 92.3%, with potential for further growth as distribution channels expand and non-licensed institutions reduce their scale [47][48].

- The report discusses a **quantitative timing model based on volume signals**, which indicates a "bullish" view for all major indices except the ChiNext Index as of January 23, 2026[30][31][33] - A **momentum sentiment indicator** is introduced, calculated as the proportion of stocks in the CSI 300 Index with positive returns over the past N days. The indicator is smoothed using two moving averages (N1=50, N2=35). When the short-term average exceeds the long-term average, it signals a bullish market sentiment[32][34][36] - The **moving average sentiment indicator** is based on the eight moving averages (8, 13, 21, 34, 55, 89, 144, 233). The indicator assigns values of -1, 0, or 1 based on the position of the current price relative to these moving averages. A value greater than 5 indicates a bullish signal for the CSI 300 Index[40][44] - The **cross-sectional volatility factor** is analyzed, showing that the CSI 300 Index's cross-sectional volatility increased week-over-week, indicating an improved short-term alpha environment. Conversely, the cross-sectional volatility for the CSI 500 and CSI 1000 indices decreased, suggesting a deteriorated alpha environment[45][46] - The **time-series volatility factor** is also evaluated, revealing that the time-series volatility for the CSI 300, CSI 500, and CSI 1000 indices decreased week-over-week, indicating a worsening alpha environment. Over the past quarter, the CSI 300 Index's volatility was in the lower range of the past six months, while the CSI 500 and CSI 1000 indices were in the middle range[46][49]

Investment Rating - The report maintains a "Buy" rating for China Merchants Bank (招商银行) [1] Core Insights - In 2025, China Merchants Bank achieved operating revenue of 337.5 billion, essentially flat year-on-year, and a net profit attributable to shareholders of 150.2 billion, representing a 1.2% increase [3][4] - The bank's return on equity (ROE) was 13.44%, down 1.05 percentage points year-on-year [3][4] - The bank's revenue and net profit growth rates improved slightly compared to the first three quarters of 2025, with revenue growth turning positive for the first time since Q1 2023 [4] - The bank's non-interest income decreased by 3.4% year-on-year, but the decline was less severe than in previous quarters, indicating a potential recovery in wealth management and asset management services [4] Financial Performance Summary - Total assets grew by 7.6% year-on-year, with loans and non-loan assets increasing by 5.4% and 10.4%, respectively [5] - The loan-to-asset ratio was 55.5%, down 1.2 percentage points from the beginning of the year, reflecting a balanced approach to loan growth amid weak demand [5] - Deposits grew at a stable rate of around 8%, with total liabilities increasing by 8% year-on-year [5] - The non-performing loan (NPL) ratio remained stable at 0.94%, with a provision coverage ratio of 391.8% [6] Earnings Forecast and Valuation - The report forecasts earnings per share (EPS) for 2025-2027 to be 6.05, 6.33, and 6.64 yuan, respectively, with corresponding price-to-book (PB) ratios of 0.82, 0.75, and 0.69 [6][8] - The bank's strategic goal is to become a "value bank," with a strong focus on retail banking, which is expected to benefit from supportive government policies aimed at boosting consumption and investment [6]

Investment Rating - The report maintains a rating of "Buy" for the basic chemical industry [5] Core Views - The report highlights that the spandex industry is at a turning point, with prices reaching historical lows and recent price increases indicating a recovery in the industry [1][2] - The report emphasizes the limited new capacity in the spandex sector and the exit of outdated capacity, suggesting a favorable supply-demand balance and a positive outlook for the spandex industry [2] - The "anti-involution" policy is expected to enhance the recovery of the "refining-chemical fiber" industry chain, with improvements in market competition and supply-demand dynamics [3] Summary by Sections Industry Overview - Spandex prices have dropped from a peak of 83,750 yuan/ton in 2021 to 23,600 yuan/ton in early January 2026, a decline of 72% [1] - The report notes that spandex production capacity in China is projected to grow from 925,000 tons in 2020 to 1,430,000 tons by 2025, with a compound annual growth rate (CAGR) of 7.6% [2] Supply and Demand Dynamics - The apparent consumption of spandex in China is expected to increase from 720,000 tons in 2020 to 1,060,000 tons by 2025, with a CAGR of 6.7% [2] - The report indicates that the spandex industry is entering a recovery phase due to the reduction in new capacity and the exit of outdated production [2] Policy Impact - The "anti-involution" policy aims to optimize market competition and improve the supply-demand balance in the refining and chemical fiber sectors [3] - The report suggests that the refining industry is nearing the end of capacity expansion, which is expected to improve supply-demand dynamics [3] Investment Recommendations - The report recommends focusing on leading companies in the polyester filament sector such as Hengli Petrochemical, Rongsheng Petrochemical, and Dongfang Shenghong, as well as spandex companies like Huafeng Chemical and Xinxiang Chemical Fiber [4]

2026 年 1 月 24 日 总量研究 REITs 二级市场价格上涨 ，多个项目状态更新至"中止" ——REITs 周度观察（20260119-20260123） 要点 1、 二级市场 2026 年 1 月 19 日-2026 年 1 月 23 日（以下简称"本周"），我国已上市公募 REITs 二级市场价格整体呈现上行趋势：中证 REITs（收盘）和中证 REITs 全收 益指数分别收于 806.72 和 1047.51，本周回报率分别为 2.09%和 2.17%。与其 他主流大类资产相比，回报率由高至低排序分别为：黄金>可转债> REITs >A 股> 原油>纯债>美股。 从项目属性来看，本周产权类和特许经营权类 REITs 的二级市场价格均有所上 涨，其中，产权类 REITs 回报率为 3.05%，特许经营权类 REITs 回报率为 1.63%。 从底层资产类型来看，本周新型基础设施类 REITs 涨幅最大。本周回报率排名前 三的底层资产类型分别为新型基础设施类、市政设施类和消费类。 从单只 REIT 层面来看，有 68 只 REITs 上涨，有 10 只 REITs 下跌。涨跌幅方面， 涨幅排名前三 ...